Cutaneous and Noncutaneous Adverse Effects in Patients with Advanced Melanoma Receiving Immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cutaneous and Noncutaneous Adverse Effects in Patients with Advanced Melanoma Receiving Immunotherapy

Published:2023-11 Issue:6 Volume:3 Page:100232
ISSN:2667-0267
Container-title:JID Innovations
language:en
Short-container-title:JID Innovations

Author:

Yeung Howa^ORCID,Supapannachart Krittin J.^ORCID,Francois Sandy^ORCID,Adler Colin H.^ORCID,Kudchadkar Ragini R.^ORCID,Lawson David H.^ORCID,Yushak Melinda L.^ORCID,Shariff Afreen I.^ORCID,Chen Suephy C.^ORCID

Funder

American Skin Association

Melanoma Research Alliance

American Cancer Society

NIAMS

Publisher

Elsevier BV

Subject

General Medicine

Reference19 articles.

1. Characteristics and management of immunerelated adverse effects associated with ipilimumab, a new immunotherapy for metastatic melanoma;Andrews;Cancer Manag Res,2012

3. Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination;Boutros;Nat Rev Clin Oncol,2016

4. Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors;Das;J Immunother Cancer,2019

5. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1);Eisenhauer;Eur J Cancer,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP